 |
|
|
| |
Evaluation of Treatment Satisfaction and Experiences Among People With HIV When Switching to B/F/TAF From CAB + RPV: Results From the Phase 4 EMPOWER Study
|
| |
| |
IDWeek; October 19-22, 2025; Atlanta, GA, USA
Samir Gupta1, Thomas Martin2, Cyril Gaultier3, Alexandra Kissling4, Kathleen Beusterien4, Megan Chen5, Megan Dunbar5, Hui Liu5, Brenda Ng5, Moti Ramgopal6
1Indiana University School of Medicine, Indianapolis, IN, USA; 2Antiviral Research Center, University of California San Diego, San Diego, CA, USA; 3BIOS Clinical Research, Palm Springs, CA, USA; 4Oracle Life Sciences, Austin, TX, USA; 5Gilead Sciences, Inc., Foster City, CA, USA; 6Midway Immunology Research Center, Fort Pierce, FL, USA
|
| |
|
|
|
|
|
